← SynDRA
OLTIPRAZ
SynDRA canonical compound SYN0005572 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
ANG | CYP2B6 | NFE2L2
Mechanism of action
nuclear factor erythroid derived, like (NRF2) activator
All known targets
ANG
CYP2B6
NFE2L2
Mechanisms of action (all sources)
nuclear factor erythroid derived, like (NRF2) activator
Drug classes
Anticarcinogenic Agents
Antiviral Agents
Reverse Transcriptase Inhibitors
Schistosomicides
Cross-references
PubChem CID:
47318
ChEMBL:
CHEMBL178459
DrugBank:
DB12539
ChEBI:
77319
Wikipedia:
Oltipraz
TTD: D0W4NM
LINCS BRD: BRD-K86972824
Synonyms
NSC-347901
CB-1400
Oltipraz (mucositis/radiation sickness/cancer)
Oltipraz (mucositis/radiation sickness/cancer), Canopus Biopharma
Syntheticdithiolethione (oral, acute radiation syndrome/mucositis/cancer), Canopus
4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione
RP-35972
Oltipraz [INN]
Oltiprazum
4-Methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione
RP-35,972
4-methyl-5-pyrazin-2-yldithiole-3-thione
5-(2-Pyrazinyl)-4-methyl-1,2-dithiole-3-thione
4-Methyl-5-(pyrazinyl)-3H-1,2-dithiole-3-thione
6N510JUL1Y
3H-1,2-DITHIOLE-3-THIONE, 4-METHYL-5-PYRAZINYL-
CHEBI:77319
NSC347901
RP 35972;NSC 347901
CCRIS 4048
4-methyl-5-pyrazin-2-yl-3H-1,2-dithiole-3-thione
BRN 0978110
Oltiprazum [INN-Latin]
OLT
EINECS 264-736-6
UNII-6N510JUL1Y
MFCD00868499
OLTIPRAZ [WHO-DD]
MLS006011663
SCHEMBL241164
CHEMBL178459
ZINC1852
DTXSID7021079
3H-1, 4-methyl-5-pyrazinyl-
EX-A646
HMS2090F09
Pharmakon1600-01502317
BCP16064
Look up OLTIPRAZ in the interactive SynDRA portal →